M.-A. Belaud-Rotureau

Author

Also Known As

Belaud-Rotureau, M., M A Belaud-Rotureau, M-A Belaud-Rotureau, M. Belaud-Rotureau, M.-A. Belaud-Rotureau, M.A. Belaud-Rotureau, MA. Belaud‐Rotureau

Publications

335

Citations

H-Index

Concepts

All Affiliations

M.-A. Belaud-Rotureau is an author at Centre National de la Recherche Scientifique specializing in cell biology, medicine, and cancer research.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	49
2	Cell Biology	2	2	49
3	Immunology	1	1	33
4	Pathology	1	1	16
5	Renal Pathology	1	1	16

M.-A. Belaud-Rotureau

Publications

318

Citations

H-Index

Page 1

	Year	Citations
Flow cytometry detection of caspase 3 activation in preapoptotic leukemic cells Françis Belloc, M.-A. Belaud-Rotureau, V. Lavignolle, Cytometry	2000	120
Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma? Thibault Dolley‐Hitze, Florence Jouan, Bénédicte Martin, British Journal of Cancer	2010	80
Early transitory rise in intracellular pH leads to Bax conformation change during ceramide-induced apoptosis M.-A. Belaud-Rotureau, Nathalie Leducq, F. Macouillard Poulletier de Gannes, APOPTOSIS	2000	53
Study of apoptosis-related responses of leukemic blast cells to in vitro anthracycline treatment M.-A. Belaud-Rotureau, Françoise Durrieu, Gilles Labroille, Leukemia Hematological MalignancyLeukemic Blast CellsMalignant Blood DisorderApoptosisImmunology	2000	33
Overexpression of the polarity protein PAR‐3 in clear cell renal cell carcinoma is associated with poor prognosis Frédéric Dugay, Xavier Le Goff, Nathalie Rioux-Leclerq, International Journal of Cancer Tumor BiologyPolarity Protein Par‐3UrologyGenitourinary CancerKidney Research	2013	16
Synthesis of Bcl-2 in response to anthracycline treatment may contribute to an apoptosis-resistant phenotype in leukemic cell lines Françoise Durrieu, M.-A. Belaud-Rotureau, Francis Lacombe, Cytometry	1999	16

Page 1